Hyperprogressive disease and its clinical impact in patients with recurrent and/or metastatic head and neck squamous cell carcinoma treated with immune-checkpoint inhibitors: Korean cancer study group HN 18-12.
- Issued Date
- 2020
- Type
- Article
- Publisher
- JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Language
- 영어
- ISSN
- 0171-5216
- Citation Volume
- 146
- Citation Number
- 12
- Citation Start Page
- 3359
- Citation End Page
- 3369
- Files in This Item:
-
-
There are no files associated with this item.
-
Items in Repository are protected by copyright, with all rights reserved, unless otherwise indicated.